The Peptide Antibody category comprises specialized compounds, including peptide fragments and linker molecules, essential for the comprehensive analysis of biologic therapeutics. These materials support… Read more
The Peptide Antibody category comprises specialized compounds, including peptide fragments and linker molecules, essential for the comprehensive analysis of biologic therapeutics. These materials support the evaluation of monoclonal antibodies and antibody-drug conjugates, which are widely utilized in treating cancers and autoimmune conditions. Laboratories rely on these high-purity peptide fragments and stable isotope labelled standards to facilitate rigorous analytical testing and method validation during drug development. Through techniques such as mass spectrometry, these compounds assist in precise impurity profiling and metabolite identification, ensuring the structural integrity and stability of the therapeutic agent. Furthermore, the inclusion of specific linker molecules allows for accurate monitoring of conjugation efficiency. These reference standards are foundational for maintaining stringent quality control across the development pipeline, enabling researchers to meet complex regulatory requirements for biologic product characterization.